Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion

Clinical Cancer Research

Volumn 3, Issue 8, 1997, Pages 1331-1338

  Hedlund, Tammy E ^a   Moffatt, Kirsten A ^a   Uskokovic, Milan R ^b   Miller, Gary J ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

26,26,26,27,27,27 HEXAFLUORO 9,10 SECOCHOLESTA 5,7,10(19),22 TETRAENE 1,3,25 TRIOL; 9,10 SECOCHOLESTA 5,7,10(19) TRIEN 23 YNE 1,3,25 TRIOL; 9,10 SECOCHOLESTA 5,7,10(19),16 TETRAEN 23 YNE 1,3,25 TRIOL; ACID PHOSPHATASE; FALECALCITRIOL; PROSTATE SPECIFIC ANTIGEN; RO 24 0291; RO 24 2201; RO 24 5531; RO 25 5317; RO 25 5318; RO 25 6760; RO 25 9022; RO 26 2198; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

ACID PHOSPHATASE; ANTINEOPLASTIC AGENTS; CALCITRIOL; CELL DIVISION; CHOLECALCIFEROL; ENZYME INDUCTION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; RECEPTORS, CALCITRIOL; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; TUMOR CELLS, CULTURED; VITAMIN D;

EID: 0030877408     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Kerr, J. F., and Searle, J. Deletion of cells by apoptosis during castration-induced involution of the rat prostate. Virchows Arch. B Cell Pathol., 13: 87-102, 1973.
2. Coffey, D. S., and Isaacs, J. T. Control of prostate growth. Urology, 17 (Suppl. 3): 17-24, 1981.
3. Isaacs, J. T., Lundmo, P. I., Berges, R., Martikainen, P., Kyprianou, N., and English, H. F. Androgen regulation of programmed death of normal and malignant prostatic cells. J. Androl., 13: 457-464, 1992.
4. Furuya, Y., and Isaacs, J. T. Differential gene regulation during programmed death (apoptosis) versus proliferation of prostatic glandular cells induced by androgen manipulation. Endocrinology, 133: 2660-2666, 1993.
5. Crawford, E. D., Eisenberger, M. A., McLeod, D. G., Spaulding, J. T., Benson, R., Dorr, F. A., Blumenstein, B. A., Davis, M. A., and Goodman, P. J. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N. Engl. J. Med., 321: 419-424, 1989.
6. Haddad, J. G. Jr., and Hahn, T. J. Natural and synthetic sources of circulating 25-hydroxyvitamin D in man. Nature (Lond.), 244: 515-517, 1973.
7. 3 production by cultured human keratinocytes and fibroblasts. Biochem. Biophys. Res. Commun., 115: 444-450, 1983.
8. Peller, S., and Stephenson, C. S. Skin irritation and cancer in the United States navy. Am. J. Med. Sci., 194: 326-333, 1937.
9. Apperly, F. L. The relation of solar radiation to cancer mortality in North America. Cancer Res., 1: 191-195, 1941.
10. Garland, C., Shekelle, R. B., Barrett-Connor, E., Criqui, M. H., Rossof, A. H., and Paul, O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet, i: 307-309, 1985.
11. Garland, C. F., and Garland, F. C. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol., 9: 227-231, 1980.
12. Gorham, E. D., Garland, F. C., and Garland, C. F. Sunlight and breast cancer incidence in the USSR. Int. J. Epidemiol., 19: 820-824, 1990.
13. Colston, K. W., Berger, U., and Coombes, R. C. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet, i: 188-191, 1989.
14. Schwartz, G. G., and Hulka, B. S. Is vitamin D deficiency a risk factor for prostate cancer? Anticancer Res., 10: 1307-1311, 1990.
15. Hanchette, C. L., and Schwartz, G. G. Geographic patterns of prostate cancer mortality: evidence for a protective effect of ultraviolet radiation. Cancer (Phila.), 70: 2861-2869, 1992.
16. Corder, E. H., Guess, H. A., Hulka, B. S., Friedman, G. D., Sadler, M., Vollmer, R. T., Lobaugh, B., Drezner, M. K., Vogelman, J. H., and Orentreich, N. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol., Biomarkers & Prev., 2: 467-472, 1993.
17. 3 in human prostatic carcinoma cells. In: J. P. Karr, D. S. Coffey, R. G. Smith, and D. J. Tindall (eds.), Molecular and Cellular Biology of Prostate Cancer, pp. 253-259. New York: Plenum Press, 1991.
18. 3. Cancer Res., 52: 515-520, 1992.
19. 3 in seven human prostatic carcinoma cell lines. Clin. Cancer Res., 1: 997-1003, 1995.
20. 3 receptors and actions in human prostate cancer cell lines. Endocrinology. 132: 1952-1960, 1993.
21. 3 on primary cultures of human prostatic cells. Cancer Res., 54: 805-810, 1994.
22. 3 are mediated exclusively through the genomic signaling pathway. Endocrinology, 137: 1554-1561, 1996.
23. 3 in the human prostatic carcinoma cell line ALVA-31. J. Steroid Biochem. Mol. Biol., 58: 277-288, 1996.
24. 3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels. Leuk. Res., 19: 65-72, 1995.
25. 3: an extraordinarily potent inhibitor of leukemic cell growth in vitro. Blood. 84: 1960-1967, 1994.
26. 3. Cancer Res., 54: 4057-4064, 1994.
27. 3 analogs: structure-function relationships. J. Pharmacol. Exp. Ther., 275: 1254-1260, 1995.
28. Velez-Yanguas, M. C., Kalebic, T., Maggi, M., Kappel, C. C., Letterio, J., Uskokovic, M., and Helman, L. J. 1α,25-dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro 24-5531 ) modulation of insulin-like growth factor-binding protein-3 and induction of differentiation and growth arrest in a human osteosarcoma cell line. J. Clin. Endocrinol. & Metab., 81: 93-99, 1996.
29. 3 are associated with enhanced activation of the vitamin D receptor. J. Biol. Chem., 270: 10551-10558, 1995.
30. Brenner, R. V., Shabahang, M., Schumaker, L. M., Nauta, R. J., Uskokovic, M. R., Evans, S. R., and Buras, R. R. The antiproliferative effect of vitamin D analogs on MCF-7 human breast cancer cells. Cancer Lett., 92: 77-82, 1995.
31. Anzano, M. A., Smith, J. M., Uskokovic, M. R., Peer, C. W., Mullen, L. T., Letterio, J. J., Welsh, M. C., Shrader, M. W., Logsdon, D. L., Driver, C. L., Brown, C. C., Roberts, A. B., and Sporn, M. B. 1α,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro 24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res., 54: 1653-1656, 1994.
32. 3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res., 55: 2822-2830, 1995.
33. Schwartz, G. G., Oeler, T. A., Uskokovic, M. R., and Bahnson, R. R. Human prostate cancer cells: inhibition of proliferation by vitamin D analogs. Anticancer Res., 14: 1077-1081, 1994.
34. 3 and prostate cancer cell proliferation in vivo. Urology, 46: 365-369, 1995.
35. 3. Endocrinology, 136: 20-26, 1995.
36. Labarca C., and Paigen, K. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem., 102: 344-352, 1980.
37. Hedlund, T. E., and Miller, G. J. A serum-free defined medium capable of supporting growth of four established human prostatic carcinoma cell lines. Prostate, 24: 221-228, 1994.
38. Hasenson, M., Lundh, B., Stege, R., Carlstrom, K., and Pousette, A. PAP and PSA in prostatic carcinoma cell lines and aspiration biopsies: relation to hormone sensitivity and to cytological grading. Prostate, 14: 83-90, 1989.
39. Young, C. Y., Montgomery, B. T., Andrews, P. E., Qui, S., Bilhartz, D. L., and Tindall, D. J. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res., 51: 3748-3752, 1991.
40. Horoszewicz, J. S., Leong, S. S., Chu, T. M., Wajsman, Z. L., Friedman, M., Papsidero, L., Kim, U., Chai, L. S., Kakati, S., Arya, S. K., and Sandberg, A. A. The LNCaP cell line: a new model for studies on human prostatic carcinoma. Prog. Clin. Biol. Res., 37: 115-132, 1980.
41. 3. Biochem. J., 295: 509-516, 1993.
42. 3 in rat kidney by on-line high performance liquid chromatography-electrospray tandem mass spectrometry Biochem Pharmacol., 49: 1099-1110, 1995.
43. Schmid, H. P., McNeal, J. E., and Stamey, T. A. Observations on the doubling time of prostate cancer. Cancer (Phila.), 71: 2031-2040, 1993.
44. 3 or its derivatives. J. Biol. Chem., 269: 2971-2981, 1994.
45. Sasaki, H., Harada, H., Handa, Y., Morino, H., Suzawa, M., Shimpo, E., Katsumata, T., Masuhiro, Y., Matsuda, K., Ebihara, K., Ono, T., Masushige, S., and Kato, S. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression. Biochemistry, 34: 370-377, 1995.
46. 3 (VD) analogues MC903, EB1089, and KH1060 activate the VD receptor: homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors. J. Steroid Biochem. Mol. Biol., 51: 137-142, 1994.